Davidra Nicole Sajna
Vorsitzender bei Hoverink Biotechnologies, Inc.
Vermögen: 249 $ am 30.11.2018
Aktive Beziehungen
| Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
|---|---|---|---|---|
| Cyrus Sajna | M | 42 |
Hoverink Biotechnologies, Inc.
 Hoverink Biotechnologies, Inc. Pharmaceuticals: MajorHealth Technology Hoverink Biotechnologies, Inc. operates as a biopharmaceutical company, which discovers, develops, manufactures, and commercializes pharmaceutical preparations and drug treatment for age-related diseases, cancer, gastrointestinal and oncological diseases and disorders. Its product candidate includes Ladavru, which is developed for treating cirrhosis ascites, cirrhosis, AIDS, and chronic pain, nausea and discomfort associated with chemotherapy. The company was founded by Cyrus Sajna on July 2, 2013 and is headquartered in Los Angeles, CA. | 11 Jahre |
Beziehungs-Chart
Beziehungen zu mehreren Unternehmen
Ehemalige Beziehungen
| Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
|---|---|---|---|---|
| James Cassidy | M | 88 |
Hoverink Biotechnologies, Inc.
Hoverink Biotechnologies, Inc. Pharmaceuticals: MajorHealth Technology Hoverink Biotechnologies, Inc. operates as a biopharmaceutical company, which discovers, develops, manufactures, and commercializes pharmaceutical preparations and drug treatment for age-related diseases, cancer, gastrointestinal and oncological diseases and disorders. Its product candidate includes Ladavru, which is developed for treating cirrhosis ascites, cirrhosis, AIDS, and chronic pain, nausea and discomfort associated with chemotherapy. The company was founded by Cyrus Sajna on July 2, 2013 and is headquartered in Los Angeles, CA. | - |
| Debbie Carter | F | - |
Hoverink Biotechnologies, Inc.
Hoverink Biotechnologies, Inc. Pharmaceuticals: MajorHealth Technology Hoverink Biotechnologies, Inc. operates as a biopharmaceutical company, which discovers, develops, manufactures, and commercializes pharmaceutical preparations and drug treatment for age-related diseases, cancer, gastrointestinal and oncological diseases and disorders. Its product candidate includes Ladavru, which is developed for treating cirrhosis ascites, cirrhosis, AIDS, and chronic pain, nausea and discomfort associated with chemotherapy. The company was founded by Cyrus Sajna on July 2, 2013 and is headquartered in Los Angeles, CA. | 5 Jahre |
| James McKillop | M | 64 |
Hoverink Biotechnologies, Inc.
Hoverink Biotechnologies, Inc. Pharmaceuticals: MajorHealth Technology Hoverink Biotechnologies, Inc. operates as a biopharmaceutical company, which discovers, develops, manufactures, and commercializes pharmaceutical preparations and drug treatment for age-related diseases, cancer, gastrointestinal and oncological diseases and disorders. Its product candidate includes Ladavru, which is developed for treating cirrhosis ascites, cirrhosis, AIDS, and chronic pain, nausea and discomfort associated with chemotherapy. The company was founded by Cyrus Sajna on July 2, 2013 and is headquartered in Los Angeles, CA. | - |
Statistik
| Land | Beziehungen | % des Gesamten |
|---|---|---|
| Vereinigte Staaten | 4 | 100,00% |
Alter der Beziehungen
Aktive
Vergangene
Herr
Frau
Aufsichtsräte
Führungskräfte
Ursprung der Beziehungen
- Börse
- Insiders
- Davidra Nicole Sajna
- Persönliches Netzwerk
